Nuveen
KOD icon

Nuveen’s Kodiak Sciences KOD Stock Holding History

Nuveen’s Portfolio KOD Stock Details KOD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.81M Buy
174,730
+79,438
+83% +$3.09M ﹤0.01% 1926
2026
Q1 		$3.63M Buy
95,292
+22,248
+30% +$575K ﹤0.01% 2027
2025
Q4 		$2.04M Sell
73,044
-48,368
-40% -$991K ﹤0.01% 2284
2025
Q3 		$1.99M Hold
121,412
– – ﹤0.01% 2297
2025
Q2 		$453K Sell
121,412
-18,276
-13% -$64.7K ﹤0.01% 2920
2025
Q1 		$392K Hold
139,688
– – ﹤0.01% 2974
2024
Q4 		$1.39M Sell
139,688
-5,761
-4% -$33.1K ﹤0.01% 2545
2024
Q3 		$380K Hold
145,449
– – ﹤0.01% 3095
2024
Q2 		$342K Hold
145,449
– – ﹤0.01% 3115
2024
Q1 		$765K Hold
145,449
– – ﹤0.01% 2808
2023
Q4 		$442K Buy
145,449
+3,769
+3% +$8.38K ﹤0.01% 3047
2023
Q3 		$255K Sell
141,680
-63,434
-31% -$224K ﹤0.01% 2991
2023
Q2 		$1.42M Buy
205,114
+73,940
+56% +$452K ﹤0.01% 2498
2023
Q1 		$813K Buy
131,174
+24,810
+23% +$174K ﹤0.01% 2678
2022
Q4 		$5.36M Sell
106,364
-16,399
-13% -$118K ﹤0.01% 1868
2022
Q3 		$6.18M Sell
122,763
-95
-0.1% -$923 ﹤0.01% 1771
2022
Q2 		$6.19M Buy
122,858
+24,665
+25% +$173K ﹤0.01% 1802
2022
Q1 		$4.94M Sell
98,193
-30
-0% -$1.17K ﹤0.01% 2068
2021
Q4 		$7.86M Sell
98,223
-10,848
-10% -$1.1M ﹤0.01% 1833
2021
Q3 		$11.2M Sell
109,071
-19,376
-15% -$1.79M ﹤0.01% 1703
2021
Q2 		$11.9M Sell
128,447
-3,563
-3% -$342K ﹤0.01% 1750
2021
Q1 		$15M Sell
132,010
-9,889
-7% -$1.35M ﹤0.01% 1537
2020
Q4 		$20.8M Buy
141,899
+12,807
+10% +$1.43M 0.01% 1240
2020
Q3 		$7.64M Sell
129,092
-103
-0.1% -$5.17K ﹤0.01% 1678
2020
Q2 		$6.99M Sell
129,195
-19,796
-13% -$1.12M ﹤0.01% 1713
2020
Q1 		$7.11M Buy
148,991
+34,621
+30% +$2.08M ﹤0.01% 1503
2019
Q4 		$8.23M Sell
114,370
-58,561
-34% -$2.13M ﹤0.01% 1701
2019
Q3 		$2.49M Buy
172,931
+90,374
+109% +$1.18M ﹤0.01% 2306
2019
Q2 		$966K Buy
+82,557
New +$734K ﹤0.01% 2759

Other funds holding KOD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Nuveen's KOD Position: Q2 2026 in Review

Nuveen increased its Kodiak Sciences (KOD) stake by 83% in Q2 2026, buying an estimated $3.09M and bringing the position to 174,730 shares worth $6.81M. The position accounts for ﹤0.01% of the portfolio, ranked #1926.

Nuveen first reported a position in KOD in Q2 2019 and has held it in 29 quarters since. The position peaked at $20.8M in Q4 2020. 201 funds tracked by Wall St. Rank hold KOD as of Q2 2026.

  • Nuveen held 174,730 shares of Kodiak Sciences worth $6.81M as of Q2 2026.
  • Nuveen bought 79,438 Kodiak Sciences shares in Q2 2026, an estimated $3.09M.
  • Kodiak Sciences made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #1926 holding.
  • Nuveen first reported a position in Kodiak Sciences in Q2 2019 and has held it in 29 quarters since.
  • Nuveen's Kodiak Sciences position peaked at $20.8M in Q4 2020.
  • 201 funds tracked by Wall St. Rank held Kodiak Sciences as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.